• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday

    8/19/22 3:54:34 AM ET
    $ALLR
    $AURA
    $AXDX
    $BBBY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ALLR alert in real time by email

    Gainers

    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) shares climbed 135.9% to close at $2.17 on Thursday.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) shares climbed 53.9% to close at $0.8480
    • after the company announced it was awarded $17.6 million Product Development Research grant by the Cancer Prevention and Research Institute of Texas to fund radiotherapeutic, Rhenium-186 NanoLiposome.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) rose 49.6% to close at $2.02 after the company announced sales have outperformed Walmart's expectations.
    • Lizhi Inc. (NASDAQ:LIZI) gained 43.1% to settle at $1.76.
    • Endo International plc (NASDAQ:ENDP) jumped 42.9% to settle at $0.4057 after dipping 23% on Wednesday. Endo International filed for bankruptcy after reaching a $6 billion deal with some of its creditors as the company sought to settle opioid-related lawsuits.
    • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) shares gained 36.2% to settle at $1.02 amid mention of the stock on Discord. Mind Medicine recently posted a Q2 loss of $0.04 per share.
    • Indonesia Energy Corporation Limited (NASDAQ:INDO) surged 33.3% to close at $7.80.
    • Wolfspeed, Inc. (NYSE:WOLF) shares surged 31.8% to settle at $112.91 after the company reported better-than-expected Q4 EPS and sales results. Additionally, multiple firms raised their price target on the stock.
    • Genius Group Limited (NYSE:GNS) jumped 28.2% to close at $8.18.
    • Weber Inc. (NYSE:WEBR) gained 27.2% to close at $10.00.
    • LightPath Technologies, Inc. (NASDAQ:LPTH) climbed 26.8% to close at $1.80.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) gained 25% to settle at $66.15.
    • Larimar Therapeutics, Inc. (NASDAQ:LRMR) surged 24.6% to close at $2.89. Larimar Therapeutics recently announced it received meeting minutes from the FDA following a recent Type C Meeting and plans to submit a complete response to the CTI-1601 clinical hold in Q3.
    • Horizon Global Corporation (NYSE:HZN) gained 24.5% to close at $2.39. Horizon Global recently posted a Q2 loss of $0.80 per share.
    • Edible Garden AG Incorporated (NASDAQ:EDBL) rose 22.9% to settle at $1.34. Edible Garden recently posted a Q2 loss of $0.68 per share.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) jumped 22.9% to close at $6.98.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 22.6% to close at $1.52.
    • Cyngn Inc. (NASDAQ:CYN) surged 21.5% to settle at $1.47. Cyngn recently posted a Q2 loss of $0.15 per share.
    • Seelos Therapeutics, Inc. (NASDAQ:SEEL) rose 21.5% to close at $1.13 as volume increases in psychedelic stocks.
    • Curis, Inc. (NASDAQ:CRIS) rose 20% to close at $1.26 after the company announced the U.S. FDA has lifted the partial clinical hold on the TakeAim Lymphoma Phase 1/2 study of emavusertib.
    • Milestone Pharmaceuticals Inc. (NASDAQ:MIST) gained 19.4% to close at $7.76. Milestone Pharmaceuticals recently posted a Q2 loss of $0.39 per share.
    • Mannatech, Incorporated (NASDAQ:MTEX) gained 17.1% to close at $23.50. Mannatech recently reported a second-quarter FY22 sales decline of 17.7% year-on-year, to $35 million.
    • Brooge Energy Limited (NASDAQ:BROG) surged 17% to settle at $8.45.
    • Canadian Solar Inc. (NASDAQ:CSIQ) jumped 15.2% to close at $45.19 after the company reported better-than-expected Q2 results and raised Q3 and FY22 sales guidance above estimates.
    • Mammoth Energy Services, Inc. (NASDAQ:TUSK) jumped 13.7% to close at $4.41.
    • Grindrod Shipping Holdings Ltd. (NASDAQ:GRIN) rose 13.2% to close at $21.70. Grindrod Shipping reported a second-quarter revenue increase of 47.1% year-over-year to $161.58 million.
    • Tellurian Inc. (NASDAQ:TELL) gained 13% to close at $4.68.
    • EQRx, Inc. (NASDAQ:EQRX) gained 12.6% to close at $5.43.
    • Silence Therapeutics plc (NASDAQ:SLN) gained 11.9% to close at $9.62.
    • Peabody Energy Corporation (NYSE:BTU) rose 11.5% to close at $25.90.
    • EnLink Midstream, LLC (NYSE:ENLC) climbed 9.9% to close at $10.81. The company recently posted upbeat quarterly sales.
    • Codiak BioSciences, Inc. (NASDAQ:CDAK) shares gained 9.1% to close at $2.52. Codiak BioSciences recently posted a Q2 loss of $0.30 per share.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) gained 8% to close at $9.89.
    • Helmerich & Payne, Inc. (NYSE:HP) gained 8% to settle at $44.00.
    • ON Semiconductor Corporation (NASDAQ:ON) rose 7.3% to close at $73.25 in sympathy with Wolfspeed, which reported better-than-expected Q4 EPS and sales results. Both companies are involved in making products in the auto sector.
    • BJ's Wholesale Club Holdings, Inc. (NYSE:BJ) climbed 7.2% to close at $74.09 after the company reported better-than-expected Q2 EPS and sales results and raised FY22 EPS guidance above estimates.
    • Keysight Technologies, Inc. (NYSE:KEYS) rose 6.2% to close at $179.70 as the company reported upbeat earnings for its third quarter and issued a strong forecast for the fourth quarter.
    • Cisco Systems, Inc. (NASDAQ:CSCO) rose 5.8% to settle at $49.37 after the company reported better-than-expected results for its fourth quarter and issued strong guidance.

     

    Losers

    • Blue Water Vaccines, Inc. (NASDAQ:BWV) shares fell 43.9% to close at $4.2850 on possible profit taking after the stock surged on Wednesday.
    • Unity Biotechnology, Inc. (NASDAQ:UBX) shares fell 37.1 to close at $0.6101 after the company reported pricing of upsized underwritten public offering.
    • TDH Holdings, Inc. (NASDAQ:PETZ) shares dipped 30.1% to settle at $2.98 after jumping 38% on Wednesday.
    • WeTrade Group, Inc. (NASDAQ:WETG) fell 28.5% to close at $5.12. WeTrade Group said, 'WeTrade and Zhixun are ready to launch an in-depth cooperative sales promotion of Zhixun's disinfectant.'
    • Accelerate Diagnostics, Inc. (NASDAQ:AXDX) fell 27.2% to close at $2.49 after the company announced the proposed public offering of its common stock.
    • ECMOHO Limited (NASDAQ:MOHO) dipped 26.1% to close at $0.1650.
    • America's Car-Mart, Inc. (NASDAQ:CRMT) declined 22.7% to close at $92.38 after the company reported worse-than-expected Q1 EPS results.
    • Veru Inc. (NASDAQ:VERU) fell 21.5% to close at $18.67.
    • GreenBox POS (NASDAQ:GBOX) dropped 21.1% to settle at $1.42.
    • LumiraDx Limited (NASDAQ:LMDX) dipped 20% to settle at $1.20 after the company reported worse-than-expected Q2 adjusted EPS and sales results.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) fell 19.6% to close at $18.55 following a Form 144 filing by RC Ventures, which suggested the firm proposed to sell 7.78 million common shares and certain call options. Additionally, Wedbush downgraded the stock to Underperform.
    • Kirkland's, Inc. (NASDAQ:KIRK) fell 18.6% to close at $5.21. The company is scheduled to report Q2 results on August 30, 2022.
    • Rite Aid Corporation (NYSE:RAD) dipped 18.5% to close at $8.57.
    • Nova LifeStyle, Inc. (NASDAQ:NVFY) dropped 18.1% to close at $0.9013.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) fell 17.4% to close at $0.45. Zacks Small-Cap Research recently published a note on the stock with a $12 valuation.
    • Exscientia plc (NASDAQ:EXAI) fell 16.8% to close at $9.55 after the company reported worse-than-expected Q2 EPS results.
    • Party City Holdco Inc. (NYSE:PRTY) dropped 16.1% to settle at $1.98.
    • Cadiz Inc. (NASDAQ:CDZI) fell 16% to close at $4.26.
    • Eargo, Inc. (NASDAQ:EAR) fell 15.7% to close at $2.64 on possible profit taking after the stock surged on Wednesday.
    • Root, Inc. (NASDAQ:ROOT) fell 15.5% to close at $17.13.
    • Calliditas Therapeutics AB (publ) (NASDAQ:CALT) dropped 15.1% to close at $18.00
    • after the company reported worse-than-expected Q2 sales results.
    • Puhui Wealth Investment Management Co., Ltd. (NASDAQ:PHCF) declined 15% to close at $0.85.
    • CI&T Inc (NYSE:CINT) fell 14.8% to settle at $11.45 after Q2 results.
    • bluebird bio, Inc. (NASDAQ:BLUE) shares fell 14.3% to close at $5.81 The FDA has approved Bluebird bio’s Zynteglo (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed for beta‑thalassemia.
    • Aura Biosciences, Inc. (NASDAQ:AURA) fell 13.5% to settle at $17.59. Aura Biosciences recently reported cash, cash on hand as of June 30, 2022 of $122.1 million.
    • Embark Technology, Inc. (NASDAQ:EMBK) dropped 13.4% to close at $11.42.
    • Lottery.com Inc. (NASDAQ:LTRY) fell 13.3% to close at $0.3641.
    • Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) fell 12.9% to close at $1.75. Cyclacel Pharmaceuticals recently said Q2 EPS results were up year over year.
    • VBI Vaccines Inc. (NASDAQ:VBIV) fell 11.4% to close at $1.09.
    • Soluna Holdings, Inc. (NASDAQ:SLNH) fell 11% to close at $3.48.
    • Hut 8 Mining Corp. (NASDAQ:HUT) fell 10% to close at $2.69 after the company launched at-the-market equity program of up to $200 million.
    • Big 5 Sporting Goods Corporation (NASDAQ:BGFV) fell 8.3% to settle at $8.57.
    • Walgreens Boots Alliance, Inc. (NASDAQ:WBA) dropped 5.3% to close at $38.24. It was reported on Wednesday the company and other pharmacy operators will be required to pay $650.6 million to two Ohio counties in an opioid case.
    Get the next $ALLR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALLR
    $AURA
    $AXDX
    $BBBY

    CompanyDatePrice TargetRatingAnalyst
    ON Semiconductor Corporation
    $ON
    2/12/2026$75.00Equal Weight
    Barclays
    ON Semiconductor Corporation
    $ON
    2/10/2026Buy → Hold
    The Benchmark Company
    Helmerich & Payne Inc.
    $HP
    2/9/2026$35.00 → $38.00Hold
    TD Cowen
    PLUS THERAPEUTICS Inc.
    $PSTV
    2/3/2026$2.00Buy
    Lake Street
    CADIZ Inc.
    $CDZI
    2/2/2026$10.00Buy
    Maxim Group
    Hut 8 Corp.
    $HUT
    2/2/2026$80.00Buy
    H.C. Wainwright
    LightPath Technologies Inc.
    $LPTH
    1/29/2026$15.00Buy
    Canaccord Genuity
    BJ's Wholesale Club Holdings Inc.
    $BJ
    1/28/2026$90.00Buy → Hold
    Jefferies
    More analyst ratings

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Group President, PSG Keeton Simon covered exercise/tax liability with 5,032 units of Common, decreasing direct ownership by 2% to 247,855 units (SEC Form 4)

    4 - ON SEMICONDUCTOR CORP (0001097864) (Issuer)

    2/12/26 6:08:03 PM ET
    $ON
    Semiconductors
    Technology

    CEO & President El-Khoury Hassane covered exercise/tax liability with 20,762 units of Common and sold $1,460,414 worth of Common (20,000 units at $73.02), decreasing direct ownership by 4% to 1,015,610 units (SEC Form 4)

    4 - ON SEMICONDUCTOR CORP (0001097864) (Issuer)

    2/12/26 6:02:52 PM ET
    $ON
    Semiconductors
    Technology

    Exec VP & CFO Thad Trent covered exercise/tax liability with 6,709 units of Common and sold $4,272,975 worth of Common (60,000 units at $71.22), decreasing direct ownership by 16% to 339,460 units (SEC Form 4)

    4 - ON SEMICONDUCTOR CORP (0001097864) (Issuer)

    2/12/26 6:00:49 PM ET
    $ON
    Semiconductors
    Technology

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Kras James E. bought $2,050 worth of shares (3,700 units at $0.55), increasing direct ownership by 102% to 7,317 units (SEC Form 4)

    4 - Edible Garden AG Inc (0001809750) (Issuer)

    1/5/26 8:51:35 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Director Amron Arthur H bought $18,900 worth of shares (10,000 units at $1.89), increasing direct ownership by 21% to 57,135 units (SEC Form 4)

    4 - MAMMOTH ENERGY SERVICES, INC. (0001679268) (Issuer)

    12/15/25 5:04:40 PM ET
    $TUSK
    Oilfield Services/Equipment
    Energy

    Chief Financial Officer Collins Jonathan M. bought $4,978 worth of shares (197 units at $25.27), increasing direct ownership by 3% to 6,444 units (SEC Form 4)

    4 - AMERICAS CARMART INC (0000799850) (Issuer)

    12/12/25 9:25:57 PM ET
    $CRMT
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Root, Inc. to Participate in the 2026 Association of Insurance and Financial Analysts (AIFA) Conference

    COLUMBUS, Ohio, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ:ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance, today announced its participation in the 2026 Association of Insurance and Financial Analysts (AIFA) Conference, taking place March 1-3, 2026, in Naples, Florida. While there will be no Company presentation, Root, Inc. will host one-on-one and group meetings with institutional investors. The investor material to be used in the meetings can be found on the home page of Root's Investor Relations website at ir.joinroot.com. The AIFA Conference is a premier gathering for leaders across the property & casualty insurance

    2/12/26 4:30:00 PM ET
    $ROOT
    Property-Casualty Insurers
    Finance

    CI&T Sharpens Its Marketing Edge with New SVP Appointment

    CI&T (NYSE:CINT), a global technology transformation specialist, has appointed agency heavyweight Sarah Painter as Senior Vice President for EMEA. Painter will lead CI&T's marketing strategy across the region to strengthen the company's presence in the UK and EMEA. Her work will focus on translating CI&T's 30-year expertise in AI and software engineering into clear value for clients, supporting commercial growth. Painter joins CI&T from her role as SVP, UKI Head of Marketing and Communications at dentsu, where she spent 13 years in senior leadership roles across brand, communications, and go-to-market strategy for large, multi-disciplinary organisations. Painter also previously held lea

    2/12/26 3:30:00 AM ET
    $CINT
    EDP Services
    Technology

    CISCO REPORTS SECOND QUARTER EARNINGS

    SAN JOSE, Calif., Feb. 11, 2026 /PRNewswire/ --  News Summary: Double-digit top and bottom-line growth exceeding our guidance, with EPS growing faster than revenueRecord revenue of $15.3 billion, up 10% year over year; GAAP EPS of $0.80, up 31% year over year; and Non-GAAP EPS of $1.04, up 11% year over yearGAAP gross margin of 65.0% and Non-GAAP gross margin of 67.5%; GAAP operating margin of 24.6% and Non-GAAP operating margin of 34.6%, both above the high end of our guidance rangeAccelerating, double-digit growth in product orders across all geographies and robust growth ac

    2/11/26 4:05:00 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $ALLR
    $AURA
    $AXDX
    $BBBY
    SEC Filings

    View All

    SEC Form S-3 filed by Allarity Therapeutics Inc.

    S-3 - Allarity Therapeutics, Inc. (0001860657) (Filer)

    2/12/26 4:18:22 PM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Grove Collaborative Holdings Inc.

    SCHEDULE 13G/A - Grove Collaborative Holdings, Inc. (0001841761) (Subject)

    2/12/26 10:59:19 AM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    Soluna Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Soluna Holdings, Inc (0000064463) (Filer)

    2/12/26 7:30:44 AM ET
    $SLNH
    EDP Services
    Technology

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on onsemi with a new price target

    Barclays initiated coverage of onsemi with a rating of Equal Weight and set a new price target of $75.00

    2/12/26 9:42:14 AM ET
    $ON
    Semiconductors
    Technology

    onsemi downgraded by The Benchmark Company

    The Benchmark Company downgraded onsemi from Buy to Hold

    2/10/26 7:17:53 AM ET
    $ON
    Semiconductors
    Technology

    TD Cowen reiterated coverage on Helmerich & Payne with a new price target

    TD Cowen reiterated coverage of Helmerich & Payne with a rating of Hold and set a new price target of $38.00 from $35.00 previously

    2/9/26 6:46:33 AM ET
    $HP
    Oil & Gas Production
    Energy

    $ALLR
    $AURA
    $AXDX
    $BBBY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    9/12/23 10:44:21 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    August 17, 2022 - FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

    For Immediate Release: August 17, 2022 Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.  “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing

    8/17/22 2:12:27 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Leadership Updates

    Live Leadership Updates

    View All

    Milestone Pharmaceuticals Appoints David Sandoval as General Counsel and Chief Compliance Officer

    MONTREAL and CHARLOTTE, N.C., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (NASDAQ:MIST) today announced the appointment of David Sandoval as General Counsel and Chief Compliance Officer. Mr. Sandoval's appointment comes as Milestone launches CARDAMYST™ (etripamil) nasal spray, the first and only approved self-administered treatment for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. CARDAMYST was approved by the U.S. Food and Drug Administration (FDA) on December 12, 2025. He will serve as a member of Milestone's executive leadership team and will provide business-focused legal counsel across all

    2/10/26 8:00:00 AM ET
    $MIST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Republic Technologies Welcomes Canadian Solar (NASDAQ: CSIQ) CFO as Special Advisor to the Board

    Republic Technologies Inc. (CSE:DOCT) (FSE: 7FM0) (WKN: A41AYF) (OTCQB:DOCKF) (the "Company" or "Republic") is pleased to announce the appointment of Xinbo Zhu as the Special Advisor to the Board and member of Republic's newly formed Infrastructure and Energy Advisory Committee (IEAC). He will serve to strengthen the Company's leadership bench with deep global experience across finance, risk management, and large-scale infrastructure business operations. Mr. Zhu currently serves as Senior Vice President and Chief Financial Officer of Canadian Solar Inc. (NASDAQ:CSIQ), a global renewable energy company with operations spanning manufacturing, project development, and asset ownership across

    2/6/26 9:00:00 AM ET
    $CSIQ
    Semiconductors
    Technology

    Dave O'Hara Joins Cadiz Board of Directors

    Former Microsoft Commercial CFO brings decades of experience in corporate finance and commercial strategy LOS ANGELES, Feb. 4, 2026 /PRNewswire/ -- Cadiz, Inc. (NASDAQ:CDZI, the ", Company", )) announced today that Mr. Dave O'Hara, a senior finance executive with extensive experience in corporate finance, commercial strategy and large-scale growth initiatives, has joined the Company's Board of Directors. Mr. O'Hara spent more than 20 years at Microsoft in senior executive leadership roles, most recently serving as Executive Vice President and Chief Financial Officer of Microso

    2/4/26 9:46:00 AM ET
    $CDZI
    Water Supply
    Utilities

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Financials

    Live finance-specific insights

    View All

    CISCO REPORTS SECOND QUARTER EARNINGS

    SAN JOSE, Calif., Feb. 11, 2026 /PRNewswire/ --  News Summary: Double-digit top and bottom-line growth exceeding our guidance, with EPS growing faster than revenueRecord revenue of $15.3 billion, up 10% year over year; GAAP EPS of $0.80, up 31% year over year; and Non-GAAP EPS of $1.04, up 11% year over yearGAAP gross margin of 65.0% and Non-GAAP gross margin of 67.5%; GAAP operating margin of 24.6% and Non-GAAP operating margin of 34.6%, both above the high end of our guidance rangeAccelerating, double-digit growth in product orders across all geographies and robust growth ac

    2/11/26 4:05:00 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress

    -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— --Company to host conference call and webcast today at 8:00 a.m. ET-- MIAMI, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal 2026 first quarter ended December 31, 2025, and provided a corporate update. "The strategy for the next generation of obesity drugs should be a combination therapy with GLP-1 receptor agonists for

    2/11/26 6:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    onsemi Reports Fourth Quarter and Full Year 2025 Results

    SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- onsemi (the "Company") (NASDAQ:ON) today announced its fourth quarter and fiscal year 2025 results: Results Highlights: Fourth quarter revenue of $1,530 millionFourth quarter GAAP gross margin and non-GAAP gross margin of 36.0% and 38.2%, respectivelyFourth quarter GAAP operating margin and non-GAAP operating margin of 13.1% and 19.8%, respectivelyFourth quarter GAAP diluted earnings per share and non-GAAP diluted earnings per share of $0.45 and $0.64, respectively2025 cash from operations of $1.8 billion and free cash flow of $1.4 billion, achieving record high free cash flow margin of 24% "We remained disciplined in our execution an

    2/9/26 4:15:00 PM ET
    $ON
    Semiconductors
    Technology

    $ALLR
    $AURA
    $AXDX
    $BBBY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LightPath Technologies Inc.

    SC 13G/A - LIGHTPATH TECHNOLOGIES INC (0000889971) (Subject)

    12/13/24 3:18:07 PM ET
    $LPTH
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by CADIZ Inc.

    SC 13G/A - CADIZ INC (0000727273) (Subject)

    12/6/24 6:52:25 PM ET
    $CDZI
    Water Supply
    Utilities

    Amendment: SEC Form SC 13G/A filed by Wolfspeed Inc.

    SC 13G/A - WOLFSPEED, INC. (0000895419) (Subject)

    12/6/24 11:56:48 AM ET
    $WOLF
    Semiconductors
    Technology